Baker Bros. Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-117,638
| Closed | -$10M | – | 117 |
|
|
2017
Q4 | $10M | Hold |
117,638
| – | – | 0.09% | 56 |
|
|
2017
Q3 | $9.99M | Hold |
117,638
| – | – | 0.08% | 52 |
|
|
2017
Q2 | $8.91M | Hold |
117,638
| – | – | 0.08% | 50 |
|
|
2017
Q1 | $7.77M | Hold |
117,638
| – | – | 0.06% | 55 |
|
|
2016
Q4 | $7.46M | Hold |
117,638
| – | – | 0.07% | 55 |
|
|
2016
Q3 | $7.49M | Hold |
117,638
| – | – | 0.07% | 60 |
|
|
2016
Q2 | $8.75M | Hold |
117,638
| – | – | 0.09% | 58 |
|
|
2016
Q1 | $7.86M | Hold |
117,638
| – | – | 0.08% | 63 |
|
|
2015
Q4 | $7.96M | Hold |
117,638
| – | – | 0.07% | 66 |
|
|
2015
Q3 | $6.29M | Hold |
117,638
| – | – | 0.06% | 73 |
|
|
2015
Q2 | $7.41M | Hold |
117,638
| – | – | 0.07% | 69 |
|
|
2015
Q1 | $5.66M | Sell |
117,638
-22
| -0% | -$1.06K | 0.05% | 73 |
|
|
2014
Q4 | $3.91M | Hold |
117,660
| – | – | 0.04% | 79 |
|
|
2014
Q3 | $3.45M | Hold |
117,660
| – | – | 0.04% | 74 |
|
|
2014
Q2 | $4.57M | Hold |
117,660
| – | – | 0.06% | 73 |
|
|
2014
Q1 | $4.94M | Hold |
117,660
| – | – | 0.06% | 70 |
|
|
2013
Q4 | $3.86M | Hold |
117,660
| – | – | 0.05% | 71 |
|
|
2013
Q3 | $3.18M | Hold |
117,660
| – | – | 0.05% | 64 |
|
|
2013
Q2 | $2.75M | Buy |
+117,660
| New | +$2.75M | 0.05% | 59 |
|